NeuroDerm Announces Enrollment in a Phase 1 Study of ND0612, a Continuous Levodopa/Ca

Thread Tools

Display Modes

11-20-2012, 09:29 AM

soccertese soccertese is offline

Magnate

Join Date: Nov 2007

Posts: 2,531

soccertese soccertese is offline

Magnate

Join Date: Nov 2007

Posts: 2,531

NeuroDerm Announces Enrollment in a Phase 1 Study of ND0612, a Continuous Levodopa/Ca

http://www.pipelinereview.com/index....s-Disease.html

Reply With Quote

"Thanks for this!" says:

sim00 (11-20-2012)

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

Similar Threads
Thread	Thread Starter	Forum	Replies	Last Post
NeuroDerm Announces Positive Results of a Phase II Study of ND0611 Dermal Patch in Pa	soccertese	Parkinson's Disease	0	11-09-2011 09:54 AM
NeuroDerm, Ltd. announced today the successful enrollment and dosing in its Phase I c	soccertese	Parkinson's Disease	1	06-03-2010 09:17 AM
Continuous intraduodenal levodopa infusion study	olsen	Parkinson's Disease	0	04-02-2010 11:31 AM
WE MOVE News...Continuous Levodopa for the Treatment of Parkinson Disease	Stitcher	Parkinson's Disease	4	09-04-2007 07:18 PM
Phase II Spheramine trials complete enrollment	pegleg	Parkinson's Disease	1	06-29-2007 05:22 AM

All times are GMT -5. The time now is 11:58 AM.

NeuroTalk Forums

Helping support those with neurological and related conditions.

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Site Navigation

NeuroTalk Online Support Groups

NeuroDerm Announces Enrollment in a Phase 1 Study of ND0612, a Continuous Levodopa/Ca

NeuroTalk Forums